Published in Medical Letter on the CDC and FDA, September 16th, 2007
Orphan Drug Nitroimidazole PA-824 for Tuberculosis
On July 5, the FDA granted orphan drug designation to nitroimidazole PA-824 (The Global Alliance for TB Drug Development) for the treatment of tuberculosis (TB), a bacterial infection of the lungs caused by the organism Mycobacterium tuberculosis.
According to the World Health Organization, TB is the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.